These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions. Boger DL, Yun W, Han N, Johnson DS. Bioorg Med Chem; 1995 Jun; 3(6):611-21. PubMed ID: 7582940 [Abstract] [Full Text] [Related]
7. Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065. Park HJ. Arch Pharm Res; 2002 Feb; 25(1):11-24. PubMed ID: 11885687 [Abstract] [Full Text] [Related]
10. Molecular basis for sequence-specific DNA alkylation by CC-1065. Hurley LH, Lee CS, McGovren JP, Warpehoski MA, Mitchell MA, Kelly RC, Aristoff PA. Biochemistry; 1988 May 17; 27(10):3886-92. PubMed ID: 3408734 [Abstract] [Full Text] [Related]
11. Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment. Needham-VanDevanter DR, Hurley LH. Biochemistry; 1986 Dec 30; 25(26):8430-6. PubMed ID: 3030397 [Abstract] [Full Text] [Related]
16. An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA. Scahill TA, Jensen RM, Swenson DH, Hatzenbuhler NT, Petzold G, Wierenga W, Brahme ND. Biochemistry; 1990 Mar 20; 29(11):2852-60. PubMed ID: 2346749 [Abstract] [Full Text] [Related]
17. Reversibility of the covalent reaction of CC-1065 and analogues with DNA. Warpehoski MA, Harper DE, Mitchell MA, Monroe TJ. Biochemistry; 1992 Mar 10; 31(9):2502-8. PubMed ID: 1547233 [Abstract] [Full Text] [Related]